WBA

Walgreens Boots Alliance Inc

Exchange: NASDAQSector: Consumer DefensiveIndustry: Pharmaceutical Retailers

Founded in 1901, Walgreens ( www.walgreens.com ) has a storied heritage of caring for communities for generations, and proudly serves nearly 9 million customers and patients each day across its approximately 8,500 stores throughout the U.S. and Puerto Rico, and leading omni-channel platforms. Walgreens has approximately 220,000 team members, including nearly 90,000 healthcare service providers, and is committed to being the first choice for retail pharmacy and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities. Walgreens is the flagship U.S. brand of Walgreens Boots Alliance, Inc., an integrated healthcare, pharmacy and retail leader. Its retail locations are a critical point of access and convenience in thousands of communities, with Walgreens pharmacists playing a greater role as part of the healthcare system and patients’ care teams than ever before. Walgreens Specialty Pharmacy provides critical care and pharmacy services to millions of patients with rare disease states and complex, chronic conditions.

Did you know?

Earnings per share grew at a -3.6% CAGR.

Current Price

$11.98

+0.00%

GoodMoat Value

$369.25

2982.3% undervalued

Profile

Valuation (TTM)

Market Cap$10.36B

P/E-1.64

EV$38.56B

P/B0.99

Shares Out864.74M

P/Sales0.07

Revenue$154.58B

EV/EBITDA—

Walgreens Boots Alliance Inc (WBA) Financial Statements

GoodMoat Analysis

Based on data as of March 26, 2026

Walgreens Boots Alliance exhibits severe financial distress, with negative profitability, cash flow, and a highly leveraged balance sheet. This profile fails the fundamental quality checks required for a value investment.

Read full analysis

The financial quality of Walgreens Boots Alliance is deeply unfavourable. The company is not profitable, with a negative operating margin of -9.5% and a negative EPS of -$10.01, indicating it fails the GAAP profitability quality indicator. Free cash flow generation is also negative, with a -3.5% FCF yield, which is far below the framework's threshold of a positive and growing FCF margin above 10-15%. The balance sheet is a significant concern, with a Debt/Equity ratio of 3.15, signifying extreme leverage and a clear weakness against the framework's preference for a net cash position and Debt/EBITDA below 1.0x. The negative ROE of -60.3% is catastrophic and indicates the company is destroying shareholder capital, falling drastically short of the sustainable high ROIC (>15-20%) quality benchmark. There is no positive revenue growth data provided to assess trajectory, and the combination of negative margins, negative cash flow, and high debt presents a picture of contracting financial quality with no near-term growth drivers to offset these fundamental weaknesses. Analysis based on data as of 2024-07-21.

WBA Financial Data

EBITDA$-1.30B

Revenue (TTM)$154.58B

Gross Profit (TTM)$26.47B

Gross Margin—

Operating Margin-9.53%

ROE-60.30%

ROA-7.77%

Debt/Equity3.15

Current Ratio0.68

FCF$-363.00M

FCF Yield-3.50%

Piotroski F-Score—

Rev/Share (TTM)$178.76

50-Day MA$11.67

200-Day MA—

Shares Outstanding0.86B

WBA Computed Insights

FCF$-363.00M

FCF Growth Rate—

EPS Growth (CAGR)-3.61%

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

WBA Financial Statements & Data

Walgreens Boots Alliance Inc (WBA) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Walgreens Boots Alliance Inc's financial performance and position as a Consumer Defensive company.

Trailing twelve-month (TTM) revenue is $154.58B. Gross profit (TTM) is $26.47B. EBITDA is $-1.30B. Earnings per share (EPS) is $-10.01. The P/E ratio is -1.64. Market capitalization is $10.36B.

Free cash flow (FCF) is $-363.00M. EPS growth CAGR is -3.61%. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 7 years from FY18 to FY24. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Walgreens Boots Alliance Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.